Immunobiochem Corporation

We deliver innovative solutions for companies
and individuals engaged in research in a range
of scientific fields, including immunology,
biochemistry and gene therapy

 

   Anton Neschadim    PhD

Director

Anton has expertise in immunology, biochemistry, gene therapy,
and biological chemistry. Anton's scientific publications and
patents span the areas of regenerative medicine, gene therapy
and cancer therapy. Anton has trained in biological chemistry,
immunology, regenerative medicine, and gene therapy at the
University of Toronto, during which time he has held more than
a dozen scholarships and awards. Anton completed training in
the CIHR Training Program in Regenerative Medicine (TPRM) at
the Toronto General Hospital, University Health Network.
He has vast experience managing industry-academia collaborations.
Prior to founding Immunobiochem Corporation, Anton was focussing
on research in the areas of therapeutics and regenerative medicine.
Anton is an associate member of the American Society of Gene and
Cell Therapy (ASGCT), a member of the Canadian Society of
Biochemistry, Molecular & Cell Biology (CSBMCB), and a member
of the Licensing Executives Society (LES). Anton is also a
founding member of the, Canadian Science Policy Centre, and
an organizing committee member of the Canadian Science Policy
Conference.

---

 

   Other Profiles Will Be Available Shortly   

 

 

 

Immunobiochem Corporation

1121 Bay Street, Suite 1906
Toronto, Ontario, Canada
M5S 3L9
Telephone: (416) 897-2789

E-mail: contact@immunobiochem.com

"Delivering Innovative Solutions for Research"